RXO
$12.7
Revenue | $1469Mn |
Net Profits | $-46Mn |
Net Profit Margins | -3.13% |
Rxo Inc’s revenue fell -11.88% since last year same period to $1469Mn in the Q4 2025. On a quarterly growth basis, Rxo Inc has generated 3.38% jump in its revenue since last 3-months.
Rxo Inc’s net profit fell -84% since last year same period to $-46Mn in the Q4 2025. On a quarterly growth basis, Rxo Inc has generated -228.57% fall in its net profits since last 3-months.
Rxo Inc’s net profit margin fell -108.8% since last year same period to -3.13% in the Q4 2025. On a quarterly growth basis, Rxo Inc has generated -217.84% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Current Year | -0.09 |
Rxo Inc’s earning per share (EPS) estimates for the current quarter stand at -0.09 - a -125% fall from last quarter’s estimates.
Rxo Inc’s earning per share (EPS) estimates for the current year stand at -0.09.
Earning Per Share (EPS) | -0.07 |
Rxo Inc’s earning per share (EPS) jumped 41.67% since last year same period to -0.07 in the Q4 2025. This indicates that the Rxo Inc has generated 41.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-07 | -0.02 | -0.03 | -50% |
2025-11-06 | -0.04 | -0.08 | -100% |
2026-02-09 | -0.04 | -0.07 | -75% |
2025-08-07 | 0.03 | 0.04 | 33.33% |